|
| |
- Syngene - New Gel Doc System Features Lightly Cooled Camera
- BTG plc: Study Shows Abiraterone Can Successfully Treat Aggressive, Chemotherapy-Resistant Prostate Cancer
- Leading School of Pharmacy selects E-WorkBook
- Leading UK Manufacturer of Laboratory Plastics Appoints Specialist B2B Agency The Scott Partnership for New PR Campaign
- Sterilin Limited Presents the Iwaki® Range of Tissue Culture Products to Combat In-Vitro Cell Culture
- ProtAffin AG granted Orphan Medicinal Product Designation by EMEA for lead anti-inflammatory product
- Lab21 expands companion diagnostic cancer testing service internationally
- Simple flow-based total nucleated cell differential
- Thermo Fisher Scientific Mass Spectrometry Instruments Used by Harvard University to Identify Proteins in Dinosaur Fossils and Cancer Pathways
- Pharmaceutical Profiles presents modified release formulation strategy at CRS 2008
- New Silicone Device Product Catalogue Now Available from Sterilin Limited
- Activaero's Watchhaler® Receives FDA 510(K) Clearance
- European biotech industry identifies the real culprits causing food price rises
- Major Cancer Centre is using Dymension 2D Gel Analysis Software
- Thermo Fisher Scientific Supplies Veeda Clinical Research with Watson LIMS
- GE Healthcare introduces ImageMaster 2D Platinum v7.0 software for improved gel electrophoresis analysis
- Pronostics to supply the School of Medicine, University of Birmingham with next generation diagnostics for autoimmune disease
- Body Organ Biomedical Corporation announces the prototype of bio cornea and enters the animal studies
- ValiRx (AIM:VAL) acquires shares in Cronos Therapeutics and Director's shareholdings
- Thermo Fisher Scientific and Genedata Join Forces to Accelerate Mass Spectrometry-Based Metabolomics Research
- IDBS founder and CEO, Neil Kipling, awarded Honorary Doctorate
- New Distributor for Syngene Image Analysis Products - Guarantees a High Level of Support and Service for Researchers in Greece
- Agilent Technologies Introduces High-Resolution Scanner for Current, Next-Generation Microarrays
- RENTSCHLER focuses on biotechnology and sells RENTSCHLER Pharma GmbH
- Marathons, mainsails and the healthcare industry
- Ariana(TM) Pharma raises EUR 1.5 million - New funding will speed growth and product development for bioinformatics decision support company
- Aquapharm and Dr. Reddy's Sign Commercial License Agreements
- ValiRx (AIM:VAL) Acquires Global Rights to Novel Compound Targeted at Prostate Cancer
- AM-Pharma announces start of second Phase II trial in Acute Renal Failure
- PANalytical and Malvern celebrate US office opening
- Thermo Fisher Scientific Named a Microsoft Pharmaceutical and Life Sciences Innovation Award Winner for Informatics Solutions
- Glide Pharma announces third new pharma partner for 2008 at BIO, strengthening its biologics pipeline
- Hybrigenics and Dualsystems enter into strategic partnership for yeast two-hybrid screens of full membrane proteins
- Senesco Signs A Supply Agreement For Polyplus-transfection's Delivery System
- Alsace BioValley announces EUR 11 million project for life sciences building hosting research, scientific expertise and services
- 6 ologen™ collagen matrix papers presented in World Ophthalmology Congress 2008 Hong Kong
- GE Healthcare introduces trial kit for 2-D DIGE experiments
- Q Chip Appoint Biotech Pioneer Ken Powell as New Executive Chairman
- Q Chip Introduces ReaXT PCR Beads for Molecular Diagnostics
- SOLVO is the exclusive commercial provider of B-CLEAR® kits and a provider of B-CLEAR® services in Europe
- Trophos appoints Damian Marron as Chief Executive Officer
- Sharing PANalytical success – new training course program
- DxS Launches Cancer Mutation Kit for K-RAS in Australia
- mtm laboratories appoints Bob Silverman as CEO
- Westover launches Health E-card to allow patients to access medical records anywhere in the world
- NextGen Sciences and Expression Pathology to provide protein biomarker discovery and measurement in tissue
- 30 June 2008, London … ValiRx (AIM: VAL), the cancer therapeutics and diagnostics company, today announces its final results for the twelve month period ended 31 December 2007.
- DuoCort Gets Orphan Drug Designation in the US for Treatment of Adrenal Insufficiency
- NUCL:CYTO SEGMENTATION IN HCS IMAGING ENABLED BY FAR-RED DYE
- Molecular Profiles Demonstrates Technique for Measuring Surface Physical Properties of Pharmaceutical Materials for Inhalation
- BioPortfolio Biotechnology and Pharmaceutical News April 2008
- Sharing PANalytical success – new training course program
- Aeon Astron Europe B.V. is recruiting distributors for its plastic and general surgery product
- Malvern Instruments presentation shows power of near-infrared chemical imaging in Quality by Design
- U.N. study says starve the poor - The World Food Economy
- Customer focus and product development leads to substantial revenue growth and continued profitability for IDBS in 2007
- Boehringer Ingelheim Chooses IDBS' PredictionBase
- Agilent Technologies Expands miRNA Microarray Catalogue with New Human, Mouse and Rat Assays
- Agilent Technologies Presents 2008 Manfred Donike Award for Sports Doping Control Excellence to German Researcher
- Polyplus-transfection Unveils a New Technology that Improves Intracellular Delivery of Small Interfering RNAs in vivo and Opens the Way to New Therapeutic Possibilities
- Sloning and the Kornberg group at Stanford University starting evaluation project regarding the synthesis of a Statistically Randomized Gene Library
- Promega enters into agreement with GeneCopoeia To deliver cloned gene content ready for multiple proteomics applications
- Organic lobby spreading ‘nonsense’ about GM, claim scientists
- Companies on the Biocitech Campus Filed More Than 30 Patent Applications in 2007
- TTP LabTech's Acumen eX3 Speeds Up Genome-wide Screening at Cancer Research UK
- Gene Bridges licenses Red/ET Recombineering to Novozymes
- BAC adds IgM and IgA matrices to its CaptureSelect Toolbox for antibody purification
- Pharmaterials receives Queens Award for Enterprise
- Cobra Biomanufacturing Launches New Website
- Merial Selects Genostar's IOGMA Metabolic Pathway Builder Bioinformatics Software
- Arrowhead – Spectra’s Expert Opinion Event on Pharmaceutical Pricing and Reimbursement to Take Place on 29th May 2008 in London, UK
- DuoCort Hosts Adrenal Insufficiency Symposium
- Syngene - Launch of Web based Filter and Lighting Selector can Help Find Optimum Gel and Blot Imaging Conditions in Seconds
- BIOTECON and MERCK start worldwide marketing alliance
- Affitech to help new Norwegian Cancer Stem Cell Center speed up biomarker discovery
- ProtAffin AG announces R&D collaboration with Intercell AG
- Acrobot awarded international quality certifications
- Simcyp releases updated Paediatric Simulator for evaluation of medicines in children
- Illumina Launches the iScanT System
- New Software and IQ/OQ/PQ Validation Procedures for Syngene Systems Help Save Time Achieving 21 CFR, Part 11 and GMP Compliance
- BTG Reports Positive Results from First Study Investigating BGC20-0166 in Obstructive Sleep Apnoea Patients
- BioInvent Interim Report: 1 January - 31 March 2008
- Activaero launches new corporate website
- Thermo Fisher Scientific Launches Micronucleus BioApplication for High Content Screening at SBS 2008
- Thermo Fisher Scientific Introduces New Integrated Liquid Handling Option for HCS
- Aeon Astron Europe B.V. announces the attaining of CE certificates for its tissue engineering product and bandage lens
- LGC to bring Abcellute’s revolutionary hepatocyte preservation technology to European researchers
- PepTcell starts safety studies for novel T-cell HIV vaccine
- Cyclacel Pharmaceuticals announces multiple presentations at American Association of Cancer Research Annual Meeting
- Simcyp Limited releases new version of the Simcyp Population-based ADME Simulator
- Astech Projects Launch REACTST - a Rapid, Effective And Complete Technical Support service
- Olympus Introduces Peerless New Bio-luminescence Imaging System at Analytica
- Thermo Fisher Scientific Launches Nanoliter Dispensing Pipette Tips
- Thermo Fisher Scientific Introduces Next-Generation Finnpipettes
- Thermo Fisher Scientific launch new products at Analytica 2008
- Thermo Fisher Scientific broadens online design and purchase capabilities for bioproduction products
- Olympus Opens Global Research and Development Centre in Munich
- Drug Patent Expirations in April 2008
- Pantec Biosolutions unveils preclinical data for novel transdermal drug delivery platform
- ProtAffin AG receives research grant
- Forbion’s Portfolio Company Transave, Inc. Raises $35 Million Through Series D Convertible Preferred Stock Financing
- New Colony Counting Software and Validation Procedures from Synbiosis Offer Antimicrobial Manufacturers a Faster Route to GMP Compliance
- Martian data and PANalytical X-ray analysis help confirm new mineral species
- Diatos pre-clinical results published in Clinical Cancer Research
- ISI’s SaaS Approach to eCTD Submissions Helps Boehringer Ingelheim Meet FDA Submission Requirements in Record Time
- Gene Bridges licenses Red/ET Recombineering to Genencor
- UNIchip protein biochips from Protagen identify significant off-target binding for TNF-alpha inhibitors
- BIOCRATES Life Sciences AG launches AbsoluteIDQT Kit for Metabolomics at Analytica in Munich
- GE Healthcare introduces PreDictor 96-well plates and HiScreen prepacked columns to improve process development efficiency
- Nature publishes study by Santaris Pharma scientists and collaborators: LNA-mediated microRNA silencing in non-human primates
- Pronota launches protein biomarker verification platform
- GE Healthcare introduces new Biacore T100 software
- BioPortfolio Biotechnology and Pharmaceutical News May 2008
- Promega ProteasMAX Improves Protein Characterization
- Cobra Biomanufacturing Wins "Best Contract Manufacturing Organisation" in ViE Awards
- Experienced recruiters turn life science headhunters
- Image Analyser used at Major US Pain Research Centre Improves Accuracy of Detecting Proteins Associated with Spinal Cord Injury
- Cyclacel Pharmaceuticals announces May 2008 corporate events
- CYCLACEL PHARMACEUTICALS PRESENTS INSIGHTS INTO THE MECHANISMS OF ITS CELL CYCLE INHIBITOR DRUGS
- BTG plc: Preliminary Results for the Year Ended 31 March 2008
- NextGen Sciences Strengthens Protein Biomarker Team with Two Key Appointments
- DR RABINDER BUTTAR IS AWARDED THE LLOYDS TSB JEWEL AWARD FOR NORTHERN BRITAIN CATEGORY: BUSINESS AND COMMERCIAL EXCELLENCE
- Trophos starts Phase II Clinical Trial of TRO19622 in Liver Disease
- BioVaria successfully launched Germany's Next Top Technologies at a unique technology transfer conference
- Cerenis Therapeutics announces successful completion of phase I clinical trial of CER-002 for treatment of cardiovascular disease
- Aquapharm strengthens board and management team
- Pantec Biosolutions appoints new Board members
- New Gel Documentation System Features High Specification Imaging at a Low Price
- Novosom granted US and European patents for RNAi-delivering Smarticles®
- Affimed validates antibody target for cancer metastasis - Results published in current issue of the Journal of Molecular Biology
- CropLife International Press Release: Plant Science Industry Urges Countries to Meet Obligations for International Trade of Living Modified Organisms
- Pharmaceutical Profiles helps break the habit of ineffective early drug development decision making
- SOLVO Biotechnology is introducing new P-gp PREDIVEZ Vesicular Transport Kit
- Agilent Expands Therapeutic Nucleic Acids Manufacturing Capacity
- Aeon Astron Corporation announces the brand ologen™ and related matters.
- Commission procrastinates on GMOs while millions of farmers worldwide are growing them
- Syngene - First CCD 2D Gel Imaging System Installed at Singapore’s New SMART Centre
- CRELUX and ProQinase establish joint crystal-grade kinase protein and structures platform
- Isogenica completes acquisition of the principal assets of Karyon CTT
- GE Healthcare introduces VivaspinTM sample concentrators for protein sample prep
- Hybrigenics announces 2007 full year results
- BioPortfolio Biotechnology and Pharmaceutical News June 2008
- Promising In Vivo Data for VAL 101 Compound - targets Pancreatic Cancer, based on GeneICE™ Gene Silencing Technology
- Melbourn Scientific is first UK CRO to routinely use Spraytec
- Lab21 expands cancer gene testing service
- Pharmaceutical Profiles appoints new VP Medical Research Imaging key to early studies, says Dr Jo Collier
- Lab21 Environmental helping to provide safe drinking water following Chinese earthquake
- GE Healthcare launches customized training courses for improving customers’ biopharmaceutical processes enhances GE Healthcare’s Fast Trak™ Training and Education portfolio
- Thermo Fisher Scientific Partners with NextDocs to Offer Comprehensive Enterprise Document Management and Workflow Solutions for the Laboratory
- Melbourn Scientific is first UK CRO to routinely use Spraytec
- PSI GAINS A FIRM FOOTHOLD IN LATIN AMERICA
- Rentschler Biotechnologie extends capacities for mammalian cell culture manufacturing
- Thermo Fisher Scientific is Presented with Two Frost & Sullivan Best Practices Awards for Market Leadership and Competitive Strategy Leadership in Informatics
- BioInvent and ThromboGenics announce a strategic alliance with Roche for TB-403, a novel anti-cancer antibody
- Horizon Discovery Commissioned to Find Drug Candidates by European Stem Cell Consortium
- Pfizer report demonstrates value of conducting virtual studies of drug-drug interactions
- ProtAffin AG strengthens Scientific Advisory Board
- Thermo Fisher Scientific Sponsors Industry Symposia on Stem Cell Research
- Cobrabio Announces Manufacturing Agreement with ViroMed for VM206RY
- GE Healthcare introduces two new high-performance chromatography media for tagged proteins
- BTG Reports Successful Completion of Treatments in VarisolveR US Phase II Safety Study
- Agilent Technologies Introduces Triple Quadrupole GC/MS, Updated Triple Quadrupole LC/MS at American Society for Mass Spectrometry
- Agilent Introduces Versatile Solution for LC Method Development Workflow
- Agilent Introduces CGH Microarray Chicken Genome
- Thermo Fisher Scientific Launches Total Solution for Super-speed Centrifuge Workflow -
- Thermo Fisher Scientific Launches New Cell Culture Excellence Program
- Global impact of biotech crops: socio-economic and environmental effects 1996-2006
- BTG plc: Acquisition of Protez Pharmaceuticals by Novartis
- Axxonis Pharma AG Berlin submits a European marketing authorisation application for Nenad® (lisuride) transdermal patch and subcutaneous infusion
- BioInvent and ThromboGenics report positive Phase I results for anti-PlGF cancer therapeutic TB-403
- Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests
- Westover Medical opens new Notting Hill clinic
- Westover launches Health E-card to allow patients to access medical records anywhere in the world
- GE Healthcare introduces HiTrap Capto IEX Selection Kit for chromatography media selection
- Protagen and GeneBio Sign Distribution Agreement for Modiro
- Trophos describes analgesic activity of neuroprotective agent TRO19622 in preclinical models of painful peripheral neuropathy
- Surgical Sealants, Glues and Wound Closure Worldwide Markets, Growth and Opportunities, 2006-2011
- Drugs and Devices in the Clinical Management of Obesity Worldwide; New Report from MedMarket Diligence, LLC
- Worldwide Wound Management, 2007-2016: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World
- Worldwide Spine Surgery Market Characterized by Many New Technologies, Dynamics and Double Digit Growth, According to New Report from MedMarket Diligence, LLC
- AM-Pharma announces EURO 7 million First Close of series C financing round
- Santaris Pharma begins human clinical testing of the world's first medicine targeted at a human microRNA
- Simcyp announces Johnson & Johnson Pharmaceutical Research and Development joins the Simcyp Consortium and licenses the Simcyp Simulator
- BAC and LFB Biotechnologies to Develop Custom Ligand for Purifying Recombinant Factor VIIa
- Pharmaceutical Profiles advances opportunities in inhaled medicines
- Acrobot appoints first distributor - Acrobot’s surgical navigation system for hip resurfacing to be distributed by Corin in UK, Germany & Australia
- DxS Announces Plans to Expand its Manufacturing Capacity
- TARGETED MOLECULAR DIAGNOSTICS and DxS ANNOUNCE A TIMELY WORKSHOP ON ASSESSING SOLID TUMOR MUTATIONS
- BioPortfolio Biotechnology and Pharmaceutical News January to March 2008
- OXFORD BIOMEDICA REPORT ENCOURAGING NEW PHASE II TRIAL RESULTS WITH TROVAX IN PROSTATE CANCER
- Lab21 acquires NPTech Ltd and appoints corporate advisors for European M&A activity
- BAC signs license agreement with Hematech
- Agilent Technologies Makes Powerful GC, GC/MS Capabilities Accessible to Wider Range of Labs
- Agilent Technologies Debuts Acquisitions, Significant Workflow Innovations at Pittcon
- Agilent Technologies Hosts China Anti-Doping Agency Officials
- GE HEALTHCARE INTRODUCES NANOVUET - FAST AND EASY-TO-USE SPECTROPHOTOMETER
- Synoptics Group acquired by Scientific Digital Imaging Ensuring Synoptics will Retain its Leading Position in Life Science Imaging
- Hybrigenics: 2007 Revenues, Significant Progress in Cancer-related R&D Programmes
- Mapreg Granted Orphan Status in Europe for its Lead Drug Candidate Under Development for Treatment of Spinal Cord Injury
- Simcyp Limited appoints Professor Carl Peck to its Scientific Advisory Board
- PREDICTIVE GENETIC TEST FOR BOWEL CANCER TREATMENT IS INTRODUCED IN THE UK
- Cobra Biomanufacturing Plc receives approval for research and development tax credit from the French Ministry for Higher Education and Research
- BAC and Octapharma to develop custom ligand for recombinant plasma protein
- European biotech industry sets the record straight on biofuels and outlines contribution of biotech to a low-carbon society
- New Books on Best Practices in Biotechnology Business Development and Biotechnology Education
- BioInvent signs deal with Bayer HealthCare for the discovery and development of therapeutic antibodies
- PRONOSTICS signs distribution agreement with MEDIPAN GmbH to sell its lead products in Europe’s largest diagnostics market
- Cyclacel Pharmaceuticals announces financial results for Fourth Quarter and Year Ended December 31, 2007
- PR 2008-4 FY 2007 earnings FINAL.pdf
- TTP LabTech Announce Licensing of Acoustic Technology for Label-free Interaction Analysis
- Nimbus changes name to Sovicell and launches new website
- GATC Biotech opens new subsidiary in Stockholm, Sweden
- Upfront Chromatography Appoints VP Sales and Marketing - Søren Pedersen to lead worldwide sales and marketing of RhobustTM
- OXFORD BIOMEDICA APPOINTS DR ALEX LEWIS AS NON-EXECUTIVE DIRECTOR
- OXFORD BIOMEDICA COMPLETES PATIENT RECRUITMENT FOR PHASE III TRIST STUDY OF TROVAX IN RENAL CANCER
- OXFORD BIOMEDICA PLC: PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2007
- Glide Pharma signs biologicals deal with major pharma company
- Take the Astech Automation Challenge at Interphex 2008
- Biocitech Celebrates its 5th Anniversary with an Occupancy Rate in Excess of 80 Percent
- Olympus adds Advanced Optigrid M Illumination System to Life Science Microscopy Range
- BTG Initiates Clinical Study of Novel Multiple Sclerosis Treatment
- Cyclacel Pharmaceuticals (NASDAQ:CYCC) to announce fourth quarter 2007 financial results on 11March 2008
- PanGenetics raises 23 million Euro in a series C financing to fund clinical advancement of its therapeutic antibody programs
- Forbion Capital Partners co-invests in €23M
- Cyclacel's David Glover to present at New York of Sciences Symposium
- Drug Patent Expirations in March 2008
- Novel, fully integrated Sample Dispersion Unit is key to Morphologi G3 particle characterization speed and repeatability
- GE broadens multi-vendor asset management portfolio
- Trophos SA Awarded USD 1.4 Million to Develop Promising Compounds in Preclinical Models of Ischemia-reperfusion Injury
- Cobra enters into manufacturing agreement to produce SARS protein in CHO cells
- ABLYNX ANNOUNCES FULL YEAR RESULTS FOR 2007
- A simple blood test can now be used to help identify a wide range of diseases
- Index Ventures invests US$80M in Adconion Media group
- ReachBio Partners with Axiogenesis to Distribute Novel Cell-Based Products in North America
- 67% OF FARMERS ARE READY TO GROW GMOS IMMEDIATELY SAYS A DEMOSKOPEA SURVEY
- Scottish biotech consortium to create new generation of drug tests
- PANalytical at PITTCON 2008 New products and new applications in New Orleans
- Dymension 2D Gel Analysis Software used at Specialist Institute To Identify Proteins Induced by an Anti-Addictive Compound
- Lab21 signs a license with Celera for one of the first diagnostic tests for cirrhosis risk in hepatitis C patients
- ERBI announces a spectacular speaker line-up for its 10th Anniversary BioPartnering Exchange Conference
- Agilent Technologies Microarrays Enable Baylor Researchers to Discover a Mechanism of Genomic “Errors” Associated with Certain Diseases
- Agilent Technologies Microarrays Play Role in Researchers’ Study of Autism’s Relationship to Extra or Missing Genes
- Agilent Technologies Introduces High-Sensitivity Protein Kit for its Bioanalyzer that Outperforms Silver-Stained Gels
- Agilent Technologies Introduces First Gene Expression Bioinformatics System Offering Guided Workflows
- Agilent's Oligo Library Synthesis Technology Used To Capture Sequencing Targets from Genomic DNA
- Global biopharmaceutical leader UCB selects IDBS’ BioBook for DMPK and Pharmacology
- Affimed Increases Series B Financing in Second Closing to Euro 30 Million (USD 45 Million)
- OXFORD BIOMEDICA ANNOUNCES DATA SAFETY MONITORING BOARD RECOMMENDATION TO CONTINUE TROVAX PHASE III TRIST STUDY OF TROVAX
- Acrux (ASX:ACR) reports compelling results of market research on Testosterone MD-Lotion
- Mbiotech to distribute Gene Bridges Recombineering Technology in Korea
- Cobra Announces Prize for Presentation on its Rapid Mammalian Protein Expression Technology, UCOE
- AM-Pharma announces appointment of new VP Clinical Development
- First G:BOX HR Gel Documentation System Installed on Jurong Island Will Contribute to Major Research Programmes in Emerging Technology Hub
- PG Economics welcomes new ISAAA brief: Global status of commercialised biotech crops 2007
- Medical Solutions enters an exclusive UK agreement with Empire Genomics, LLC as a distributor and service provider for ACCUArray genotyping
- Moths in Oxford Aid Drug Discovery
- 2008 is a decisive year for the validation of the asthma target interleukin-13
- Biocitech Companies Scoop EUR 100 Million in January
- Gastrotech completes $6 million Series D fundraising
- Trophos SA Receives Grant from The Michael J. Fox Foundation to Evaluate Compounds in Parkinson's Disease Model
- Illumina Sequences the First African Human Genome
- Medical Solutions becomes first UK commercial service provider of Illumina next generation DNA sequencing and genotyping applications
- Diabetes, Growth Disorders Drive Sales of Pediatric Hormone Drugs
- Astex Receives IND Approval for its Small Molecule HSP90 Inhibitor AT13387
- New Technology Combinations and Innovations to Propel Cell-Based Diagnostic Market to Nearly $9 Billion by 2011
- More Competitors and Compatibility Opens Up Multi-Billion-Dollar Gene Expression Analysis Market
- Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine
- mtm laboratories launches CervatecT Assay for cervical cancer screening
- First time at Analytica for Malvern’s Morphologi G3
- OSLO BIO UPDATE - NEWSLETTER FEBRUARY 2008 - the life science cluster in the Oslo region
- OBU_Feb08.pdf
- Mole Genetics launch first "personal" automated DNA purification system for under Euros 10,000
- Midatech secures exclusive position to exploit magnetic noble metal nanoparticles through new IP licenses
- Drug Patent Expirations in February 2008
- RICERCA BIOSCIENCES, LLC APPOINTS R. IAN LENNOX Chief Executive officer
- Polyplus-transfection has produced the first GMP-quality clinical batch of its nucleic acid transfer agent
- New Microbiology Imaging Software Offers Fast, Accurate Analysis of Colony Numbers and Zone Sizes
- BTG plc commences first clinical study of novel migraine treatment
- "Alsace Biovalley(TM)" gives new boost to Alsace region life science and healthcare
- ProtAffin AG appoints Dr. Simon Moroney to Supervisory Board
- Gastrotech signs licensing agreement with Eli Lilly following positive clinical data on compound for Irritable Bowel Syndrome
- COBRA ANNOUNCES MANUFACTURING AGREEMENT FOR TNFERADE
- Quantum Genomics Corp Partners with Inserm in Stroke and Cardiac Ischemia Drug Development
- Biotech industry supports Europe's Renewable Energy Directive and its sustainability criteria for biofuels
- GE HEALTHCARE CUSTOMERS REALIZE BEAUTY OF SCIENCE AS RESEARCH TO BE PUBLISHED IN TIMES SQUARE
- BTG plc: Interim Management Statement
- Lab21 launches cancer gene testing service
- ROBERT A. SCOTT, M.D., APPOINTED CHIEF MEDICAL OFFICER OF CERENIS THERAPEUTICS
- Endotis Pharma Raises €25 million in a Second Financing Round led by the Wellcome Trust
- Without Lifting the Lid: TTP LabTech Take Tube Volume Detection to the Next Level
- Malvern launches ISys 5.0 – powerful chemical imaging analysis software for cross-platform analysis
- Thermo Fisher Scientific Honored with Prestigious Market Leadership Award for High Content Screening Offering
- OXFORD BIOMEDICA ANNOUNCES DEVELOPMENT MILESTONE IN ITS COLLABORATION WITH MOLMED
- INDEX VENTURES ANNOUNCES €400 MILLION GROWTH FUND
- Cobra Biomanufacturing appoints Chief Operating Officer
- BioInvent and ThromboGenics Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer
- PANalytical and CERN collaboration brings first commercial application of Medipix2
- Malvern ® Instruments acquires Viscotek Corporation
- More Competitors and Compatibility Opens Up Multi-Billion-Dollar Gene Expression Analysis Market
- New Technology Combinations and Innovations to Propel Cell-Based Diagnostic Market to Nearly $9 Billion by 2011
- PFIZER AND SCIL FINALIZE AGREEMENT FOR NOVEL CARTILAGE GROWTH FACTOR
- Pantec Biosolutions presents new drug delivery platform at Drug Delivery Partnerships 2008
- Molecular Partners AG collaborates with Centocor Research & Development, Inc.
- Protagen raises €1 million to expand its protein biochips business unit
- BioInvent and Genentech Initiate Phase I Clinical Trial for BI-204, a potential treatment for cardiovascular conditions associated with atherosclerosis.
- Renowned scientist opens new PANalytical offices
- GE HEALTHCARE PRESENTS NEW DATA MANAGEMENT SOLUTION FOR HIGH CONTENT ANALYSIS AND SCREENING
- GE HEALTHCARE ANNOUNCES STRATEGIC PARTNERSHIPS WITH PROCESS ANALYSIS AND AUTOMATION AND MATRICAL TO EXTEND ITS HIGH CONTENT ANALYSIS OFFERINGS
- French biotech crop decision environmentally unfriendly
- A new, unique and unrivalled Rat/Mouse PINP assay for Pharmaceutical, Clinical and Academic Research Organizations.
- ProtAffin AG completes second closing of Series A financing
- CEVEC again successful in challenge to Crucell patent
- NOVACTA RECEIVES £3.5 MILLION STRATEGIC TRANSLATION AWARD FROM THE WELLCOME TRUST TO TARGET C.DIFFICILE INFECTIONS
- ARTES and Minapharm sign long-term strategic development agreement
- Major Veterinary Centre to Increase Throughput of Antibiotic Potency Testing By Installing Sixteen ProtoCOL Automated Inhibition Zone Sizing Systems
- Thermo Fisher Scientific Launches New Stem Cell Solutions Program
- New Olympus UIS2 objectives completes the ultimate ergonomic solution for cytology applications
- Agilent Technologies Completes Acquisition of Velocity11, a Leader in Life Science Lab Automation and Robotics
- Pharmaceutical Profiles seminar success
- Illumina Introduces the InfiniumR High-Density (HD) Human1M-Duo and Human610-Quad BeadChips
- Syngene Unveils First Multi-application Single Lighting Module For Rapidly Imaging Fluorescent Dyes with a G:BOX Chemi Image Analyser
- Breaking Rules and Bucky Balls - Eminent list of plenary speakers announced for MICROSCIENCE 2008
- Drug Patent Expirations in January 2008
- Gene Bridges granted Korean Patent for Recombineering Technology
- Biotech industry welcomes European Commission's communication on European Lead Market Initiative
- NextGen Sciences Announces Commercial Alliance with Paragon Bioservices, Inc
- OXFORD BIOMEDICA SECURES EXCLUSIVE LICENCE TO KEY INTELLECTUAL PROPERTY FOR RNA INTERFERENCE GENE SILENCING USING LENTIVECTOR TECHNOLOGY
- Positive Phase I and pre-clinical data suggest Acambis’ M2e-based universal influenza vaccine, ACAM-FLU-A™
- Astech Raise the Bar of Inhaler Testing
- BioPortfolio Biotechnology and Pharmaceutical News October to December 2007
- Agilent Technologies Announces Biggest Sale in India to Date: More than 50 Liquid Chromatography, Nine Gas Chromatography Systems
- Ablynx extends agreement with Wyeth
- Olympus digital microscope camera range offers flexibility for any application
- Syngene New GeneSnap Image Acquisition Software Promises Reproducible - Gel Imaging in Seconds
- New time for Cyclacel conference call for update on Sapacitabine Phase II plans
- Santaris Pharma raises €20 million of new equity
- Ablynx reports positive Phase I results for its anti-thrombotic NanobodyR, ALX-0081
- Biopartners terminates collaboration with The Medical House
- PepTcell and Gador Announce Collaboration to Develop Novel Vaccine for "Neglected" Chagas disease
- Simcyp - Virtual trials could improve drug development
- OrphaMed selects IDBS' fully integrated data management system
- 10th Annual Customer Experience Conference: Using Quality to Improve the Customer Experience
- Equinox launches world’s first pay per use service (PPU) for bioinformatics software
- OXFORD BIOMEDICA INITIATES PHASE I/II TRIAL OF PROSAVIN GENE-BASED TREATMENT FOR PARKINSON'S DISEASE
- Cyclacel Pharmaceuticals to host conference call on upcoming Sapacitabine Phase II trials
- Forbion Capital Partners leads EUR30M Series B Financing in Fovea Pharmaceuticals S.A
- Dyversity 2D Gel Image Analyser used at Major UK University To Help Accurately Detect Proteins Associated with Stem Cell Differentiation
- Protagen and Tomy Digital Biology announce distribution agreement for Modiro™ in Japan
- ABLYNX ANNOUNCES EXTENSION OF NANOBODY® DRUG DISCOVERY AND DEVELOPMENT ALLIANCE
- Magnisense Appoints Hayat El Yousfi Marketing and Clinical Trials Manager
- OXFORD BIOMEDICA ANNOUNCES DATA SAFETY MONITORING BOARD RECOMMENDATION TO CONTINUE TROVAX® PHASE III TRIAL IN RENAL CANCER
- CYCLACEL REPORTS UPDATED PHASE I SAPACITABINE DATA
- Genentech/Roche: FDA may still approve Avastin despite setback
- New strategy to reduce multiple births & complications after fertility treatment
- Accelrys and Agilent Technologies Enter Into Comprehensive Resale Agreement
- Agilent Technologies and BioNanomatrix to Develop Genetic Analysis System Using Nanoscale Whole Genome Imaging Technology
- Agilent Technologies Integrates ICP-MS with Enterprise Content Management System for Regulated Pharma Applications
- Agilent Technologies Signs Agreement to Acquire Velocity11, a Leader in Life Science Lab Automation and Robotics
- Pharmaceutical Profiles maintains GMP certification
- Lisuride sc infusion therapy has proved highly effective in reducing severe motor complications in patients with advanced Parkinson’s Disease (PD) refractory to optimized oral therapy.
- Pressrelease_AXX_CALIPSO_061207_2.pdf
- OXFORD BIOMEDICA WINS SCRIP’S LICENSING DEAL OF THE YEAR AWARD
- M&A IS TRANSFORMING THE BIOTECH LANDSCAPE, SAYS INTERNATIONAL BIOTECHNOLOGY TRUST PLC
- Cyclacel Pharmaceuticals to present Sapacitabine Phase I data at US American Society of Hematology conference
- Qualyst and Solvo Biotechnology announce alliance for B CLEAR® in Europe
- BioInvent Designates Drug Candidate, BI-505, for the Treatment of Cancer
- HRA Pharma enters licensing agreement with PregLem to develop and commercialise ulipristal for gynecological disorders
- Icelandic Biotech Company Introduces First-ever Biorisk-free Growth Factors to Global R&D Market
- THE WORLD ECONOMIC FORUM ANNOUNCES TECHNOLOGY PIONEERS 2008: OXITEC SELECTED
- Senior appointments further strengthen Pharmaceutical Profiles scientific expertise
- Immutep Announces Positive Interim Results From a Study of Immufact(R) IMP321 in Metastatic Breast Cancer
- OXFORD BIOMEDICA WINS TECHMARK AWARD
- EU-US authorities to harmonize medicines approval process
- CLINTEC INTERNATIONAL TO LOCATE GLOBAL HEADQUARTERS IN SCOTLAND CREATING UP TO 240 NEW JOBS
- NextGen Sciences Announces Collaboration with the Harvard Institute of Proteomics
- Brane Discovery commences Phase I trial of BND-11624 for neuropathic and osteoarthritic pain
- Cyclacel Pharmaceuticals announces pipeline update
- Cytheris appoints Richard Keatinge as Chief Business Officer
- Next Generation Multi-application Imaging and Analysis System Perfectly Combines Accuracy with Versatility
- Q Chip's ReaXT Assays speed up bacterial identification
- Biota (ASX:BTA) announces LANI Phase II trial commencement
- Northbank Communications Strengthens Team with Four PromotionsNorthbank Communications Announces Appointment of New Account Executive
- Northbank Communications Strengthens Team with Four Promotions
- SOLVO Biotechnology among the region’s fastest growing
- SANTEN BEGINS CLINICAL TRIALS WITH OAKWOOD-MANUFACTURED PRODUCT
- OXFORD BIOTECH INVESTMENT BUOYANT DESPITE MARKET TURBULENCE
- Bionest Partners Outlines Winning Pathways for BioPharma Companies in Oncology
- Agilent & BioTrove Collaborate for Ultra-High-Throughput Mass Spectrometry Solution
- InferMed appoints new Director of Product Development to Executive Team
- DBV TECHNOLOGIES STENGTHENS BOARD OF DIRECTORS AND SCIENTIFIC ADVISORY BOARD
- BAC launches CaptureSelect toolbox for antibody purification
- SOLVO Biotechnology (Hungary) and KRISHGEN BioSystems (India) announce Distribution and Service Representation Agreement for SOLVO’s Membrane Transporter Assay Products and Services in India, Singapore, Malaysia, Hong Kong, Thailand, Srilanka, Bangladesh
- NextGen Sciences Appoints New CEO and Expands Service Offering to Include Protein Biomarker Monitoring
- Molecular Partners Appoints Jörn Aldag as Chariman of the Board
- Santaris Pharma's HIF-1 alpha antagonist begins second phase 1 study against solid tumours and lymphoma
- BioInvent and ThromboGenics Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell
- Pharmaceutical Profiles study shaves months and millions off drug development program
- National Heart and Lung Institute Uses G:BOX Chemi HR16 Imager To Help Identify Proteins Associated with Heart Disease
- Quantum Genomics Corp Widens Net with Acquisition of Eurobiobiz SAS
- Magnisense Will Give Talk at MMM'52
- OXFORD BIOMEDICA AND SIGMA-ALDRICH WIN KEY RULING IN OPEN BIOYSTEMS PATENT INFRINGEMENT DISPUTE
- Biota (ASX:BTA) announces Relenza royalties of AU$4.5M
- Cobra Biomanufacturing to Support Development of the University of Rochester's HIV Vaccine Platform
- Ipsat Therapies Announces Positive Top-line Data from Phase IIb Study of Ipsat P1A
- IDBS announces the release of E-WorkBook Suite 7.1
- Diatos announces successful completion of Phase I trial for DTS-201, a novel doxorubicin prodrug
- Promega introduces new HaloCHIPT System
- Q Chip Introduces ReaX™ Assays Range
- Cobra Signs Agreement with Advaxis to Manufacture Lovaxin C Vaccine
- Borean Pharma receives Notice of Allowance of HIV drug patent by U.S. Patent & Trademark Office
- POLYPURE INTRODUCES KEY MONODISPERSED PEG COMPOUND
- RICERCA BIOSCIENCES, LLC APPOINTS DR. JAMES R. SZABO Vice President–biology services
- BioInvent Interim Report 1 January – 30 September 2007
- Diatos Announces Start of the Preclinical Toxicology Program of DTS-108, a second generation irinotecan
- Auto-Montage Pro Software Used at Respected UK Teaching Hospital To Confirm Diagnosis of a Parasitic Disease Unusual to the UK
- Spain prevents automatic substitution of biological medicines, providing clarity for pharmacists and patients
- Pharmaceutical Profiles to share unique expertise
- Lab21 Announces Licence Agreement with Ark Therapeutics for Predictive Coronary Heart Disease Diagnostic
- Ablynx announces intention to launch an Initial Public Offering (IPO) on Eurolist by Euronext Brussels
- Automated Colony Counter Generates Accurate OPKA Assay Results
- ClinTec International expands their full-service capabilities in Germany
- Pharma Sales Force Effectiveness: Increasing Productivity Through Streamlined Internal Communication
- Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
- OEM Contract Manufacturing to Grow $11 Billion by 2011
- Advancements in Population Age and Technology
- DNA Sequencing Equipment Market to Fragment and
- Worldwide Skin-Ulcer Treatment Market to See New Growth,
- Efforts to Improve Efficiency of Drug Discovery Expected to Grow
- World Physician Office Lab Point-of-Care Diagnostics Market to Reach $2.4 Billion by 2011
- Imports and Age Expected to Electrify Asian Medical Device
- Market Potential for Tuberculosis Testing Products and Therapeutics Tops $8 Billion
- Promising New Drug and Other Trends To Double Smoking Cessation and Addiction Treatments Market by 2010
- With Promise of Personalized Medicine, World Molecular Imaging Market Set to Reach $4.75 Billion in 2010
- At $42 Billion by 2011, Immunological and BioTherapy Cancer Treatments Near 50% of Market
- World Antiviral Market Primed to Reach $24.9 Billion by 2011
- Faltering Antibiotics Market to Recover and Surpass $25 Billion by 2010
- As Transdermal Drug Delivery Gains Acceptance, Market Shoots to $7.9 Billion
- Popularity of LASIK Helping to Drive World Refractive Vision Correction Market to $4.5 Billion by 2009
- Total Pulmonary Drug Delivery Market Expected to Top $34 Billion by 2010
- Pharmaceutical Profiles to host round table workshop at Bench2Boardroom 2007
- BioPortfolio Biotechnology and Pharmaceutical News July to September 2007
- London Genetics facilitates partnership between Oxford Gene Technology and Northwick Park Hospital
- GE Healthcare launches IN Cell Analyzer Image Competition 2007: Win a trip to New York
- Significant changes in store for growing HIV market
- Pharmaceutical product lifecycle management technology gaining momentum
- New treatments will drive fibromyalgia market forward
- Targeted therapies promise new hope for brain cancer patients
- Electronic prescribing: pharma seeks to maintain influence
- Pandemic flu threat question remains unanswered
- High Court's ruling on Alzheimer's drugs may have global implications for patient power
- oSmithKline: Avandia to stay but damage is done
- MERIT trial leaves role of Pfizer's Celsentri unclear
- Novartis: underlining its strong position in the flu vaccine market
- Generic erosion inevitable, but can be reduced
- Changing of the guard in HIV treatment
- RSV: lack of vaccine puts most vulnerable at risk
- Need for new drugs to tackle 'superbugs'
- IT in translational medicine: from data to drugs
- Targanta Therapeutics: IPO based on oritavancin
- New drug class to broaden treatment options for insomnia
- Cardiovascular disease to become leading cause of death worldwide by 2020
- Array BioPharma initiates clinical trials of cancer drug
- Biogen and Vernalis start Parkinson's trial
- FDA requests additional efficacy data for Dendreon's Provenge in advanced prostate cancer.
- Bristol-Myers and Isis to collaborate on heart drugs
- Meda and Ethypharm collaborate on NSAID
- Breaking Merck patent may drive investment away from Brazil
- Alkermes and Indevus start pulmonary disease study
- Ranbaxy gets final authorization for generic Ambien
- Pfizer's CCR5 inhibitor for HIV treatment has won backing from an FDA advisory panel.
- Cerus considers immunotherapy spin off
- Common pain medications do not prevent Alzheimer's disease
- Senate bill pushing for government drug price negotiations is unlikely to save cash
- Hormone therapy linked to increased incidence of ovarian cancer
- Gemin X compound effective in leukemia
- UCB epilepsy drug effective for pediatric patients
- Schering-Plough receives Japanese approval for Zetia
- Gilead reports positive data for cystic fibrosis antibiotic
- Novoxel seeks to pre-empt MRSA drug concerns
- Northbank Communications Joins College Hill
- Future of Clinical Trials in Europe: Biotech industry's keys for change
- IDBS and Titian to provide complete solution for drug discovery market
- Nitec Pharma expands senior management team
- Magnisense Strengthens Management Team with Technical Development Manager
- Publication of key performance data for the CellMaker Lite2 with yeast cells (Pichia pastoris)
- Launch of Flagship CellMaker PLUS™ - the World’s first dual-mode single-use bioreactor
- Lab21 completes partnership deal with Monogram Biosciences to enable launch of HIV Trofile TM assay in UK
- deltaDOT Ltd receives £3 million ($6.05 million) from investors
- AUSTRIANOVA establishes Singapore subsidiary
- Trophos Starts Phase Ib Clinical Trial of TRO19622 in Spinal Muscular Atrophy
- CODEX paving the way for safety assessment of products with GM low level presence
- Acrobot and Stanmore Implants announce computer assisted surgery collaboration
- MorphoSys Granted Further U.S. Patent for its Core Antibody Technology HuCAL
- Northbank Welcomes Back Dr Marc Egelhofer to London Team
- Agilent Offers First FFPE Kit for Oligo CGH Microarrays
- gilent's Microarray Genomic Platforms Derive New Type of Mouse Embryonic Stem Cell
- DBV Technologies and Numico (€2.6 billion of revenues in 2006) enter into an exclusive distribution agreement
- ABLYNX IS AWARDED EUR 1.9 MILLION GRANT TO EXPLORE NEW THERAPEUTIC USES OF NANOBODIES
- Amorphous and partially amorphous drug analysis and formulation takes centre stage through Synectix
- PROIMMUNE LAUNCHES NEW MHC-PEPTIDE BINDING ASSAY FOR CLASS II HLA ALLELES
- GATC Biotech announces collaboration agreement to develop comprehensive DNA-based sepsis diagnostic
- Nitec's IND application for clinical development with Lodotra accepted by the FDA
- Milestone reached as PANalytical celebrates 5th anniversary!
- University of Surrey to use Cambridge Cell Networks' ToxWiz software to assist their research on Compound Safety Assessment.
- GE Healthcare's IN Cell Analyzer Recognized with 2007 Frost & Sullivan Technology Innovation Award
- Polyplus-transfection to Supply RNAi Therapeutic Delivery Technology to Alnylam Pharmaceuticals
- Pharmaceutical Profiles IP confirmed on core company technology
- MorphoSys Announces Clinical Milestone in Antibody Program
- Experienced Stem Cell Industry Management Team Opens Doors to New Contract Services Business
- AM-Pharma announces appointment of Chief Business Officer
- DBV TECHNOLOGIES EXPANDS MANAGEMENT TEAM AND MOVES TO NEW FACILITIES IN PARIS
- IntegraGen appoints Bernard Courtieu as CEO in a move to accelerate its commercial efforts
- Scientific results presented at ICAAC demonstrate the well-differentiated profile and broad spectrum of BioAlliance Pharma's antifungal
- Immutep Announces That ImmuFact(R) IMP321 Induces Activation of a Wide Range of Human Effector Cytotoxic Cells
- Genmab expands use of IDBS’ ActivityBase Xtended Edition in Hybridoma Discovery
- TTP LabTech’s European Roadshow - INNOVATIVE AUTOMATION ROADSHOW
- BioAlliance Pharma Launches its First Product, Loramyc(R), on the French Market
- BioAlliance Pharma Announces First Half 2007 Results
- Trophos Closes EUR 8.5 Million in Series C Funding
- Biocitech Technology Park Announces Oroxcell and Mutabilis
- 4th Annual Asia Pacific BioScience Forum, London, 11 October 2007
- InferMed appoints Cancer Research UK's Dr Sally Burtles as Observer to the Board
- OXFORD BIOMEDICA REACHES FIRST MILESTONE IN TROVAX COLLABORATION WITH SANOFI-AVENTIS
- OXFORD BIOMEDICA PLC: INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2007
- Acambis - FDA approves ACAM2000T vaccine for protection against smallpox
- Meet the experts in San Diego - Pharmaceutical Profiles to host oral modified release formulations seminar
- EDEN BIODESIGN AND BOREAN PHARMA APS SIGN DEAL TO DEVELOP NOVEL THERAPEUTIC CANDIDATE FOR THE TREATMENT OF CANCER
- ALPHA BIOLOGICS PENANG MANUFACTURING FACILITY NEARS COMPLETION
- New low-volume disposable cuvette extends protein analysis capabilities of the Zetasizer® Nano
- New Chemiluminescent Application of G:BOX Image Analyzers
- ProtAffin AG strengthens Scientific Advisory Board with two new appointments
- Publication of key performance data for the CellMaker PLUS™ with CHO-S cells
- Northbank picked to make the difference to BTG’s communications
- European biotech industry releases policy on Biofuels in Europe
- SOLVO Biotechnology has received the ISO 9001:2000 Quality Management System Certification
- Antibiotics and Drug Resistance 2007 - New drug innovation and the strategy to combat antibiotic resistance mechanisms
- Global cardiovascular drug market to hit $116.3billion by 2010 forecasts URCH Publishing
- Molecular Partners Raises 18.5 Mio CHF (€11.28 million, $15.56 million) in Series A Financing
- New syphilis test provides quicker and easier diagnosis
- Synbiosis - Leading European Skin Disease Centre Uses ProtoCOL
- Promotion and New Appointment in Northbank’s Congleton Office
- London Genetics enhances its partnering capabilities by establishing a Scientific Advisory Board
- Olympus introduces updated dotSlide virtual microscopy system: Virtual Slide: Real Analysis
- Lab901 launches the ScreenTapeR system for rapid and fully automated gel electrophoresis
- OXFORD BIOMEDICA ANNOUNCES DATA SAFETY MONITORING BOARD RECOMMENDATION TO CONTINUE TROVAX® PHASE III TRIAL IN RENAL CANCER AS PLANNED
- SVS independently validates IDBS’ E-WorkBook Suite against 21 CFR Part 11 and GLP requirements
- Simcyp strengthens its activities with the appointment of Professor Malcolm Rowland as Chairman of its Scientific Advisory Board
- Dutch biotech AM-Pharma announces 2.5 Million Euro financing
- Immunodiagnostic Systems Holdings PLC - Proposed acquisition of Biocode Hycel S.A.
- Prosarix and ChemOvation enter into co-development and licensing agreement
- TTP LabTech Announce US Expansion to Meet Growing Customer Demand
- OXFORD BIOMEDICA: PUBLICATION OF TROVAX® PHASE II CLINICAL TRIAL DATA
- Cambridge Healthcare & Biotech receives seal of approval for commitment to client focus and quality.
- ACRUX ESTRADIOL SPRAY APPROVED BY FDA
- Northbank Communications Strengthens Media Team with Promotion
- Cobra Biomanufacturing Collaborates On Space Research
- Acrobot secures £2.6 million investment in equity financing round
- MARK T. CRANE, VICE PRESIDENT OF BUSINESS DEVELOPMENT AND MARKETING, BRINGS LEADERSHIP AND EXPERTISE FROM CAREER WITH TOP PHARMACEUTICAL SERVICE PROVIDERS
- CERENIS THERAPEUTICS ANNOUNCES THE ADDITION OF THREE PHARMACEUTICAL INDUSTRY VETERANS TO ITS MANAGEMENT TEAM
- Lectus Therapeutics strengthens management team and SAB
- New DigiGenius Gel Documentation System Promises High Quality, yet Affordable Automated Imaging
- Thrombotargets Corporation and Dr. Cam Patterson, Director of the Carolina Cardiovascular Biology Center at the University of North Carolina to create a Joint Venture for the exploitation of their proprietary technologies.
- Thrombotargets Corporation announces the incorporation of Steven Hite as a Chief Operating Officer based in North Carolina, USA.
- Thrombotargets Corp. and Magellan Bioscience Group, Inc. to collaborate on identification of novel hits from both marine derivate and natural products.
- Thrombotargets Corp announced today that it has submitted its Orphan Drug Application of TT-103MH to the FDA for bleeding treatment in von Willebrand patients
- Solvo Biotechnology Announces Appointment of Yuichi Sugiyama to the Scientific Advisory Board Budaörs, Hungary – July 20th, 2007
- Astech launch new X-range of drug delivery automation products
- Amsterdam Molecular Therapeutics raises additional €5.67 million in IPO following partial exercise over-allotment option
- Virax HIV immunotherapeutic Phase IIa clinical trial results peer reviewed in Human Vaccines Journal
- ClinTec International recruits Executive Vice President – Asia as part of a continued drive to evelop the Asian clinical research marketplace.
- EuropaBio welcomes new EMEA technical document on biosimilars
- Cancer Stem Cells Emerging Therapeutic Diagnostic and Market Opportunities
- Secondary endpoints of phase II/III study confirm clear benefits from treatment with removab® for patients with malignant ascites
- Acambis starts clinical testing of universal influenza vaccine
- deltaDOT will play key analytical role in the US Defense Advanced Research Projects Agency (DARPA) drive to accelerate vaccine production
- OXFORD GENE TECHNOLOGY APPOINTS DR TIM COOK TO THE BOARD
- Australian drug delivery company Acrux delivers on male testosterone replacement lotion
- IDBS Renews Participation in SAFE-BioPharma Association’s Vendor Partner Program
- ProtoCOL Automated Colony Counter Is Helping Speed up Development of Novel Vaccine Technology
- mtm laboratories announces new pivotal trial data resulting in European launch of the CINtecR Histology kit with extended clinical claims
- BioInvent Interim Report
- LifeCycle Pharma to Initiate Phase II Clinical Trial of LCP-AtorFen for the Treatment of High Cholesterol Levels
- InferMed establishes Strategic Partnership with NNIT to host clinical trials Electronic Data Capture solution
- Malvern Zetasizer Nano provides protein insight for both students and researchers at University of Massachusetts
- Pronota awarded Euro 1.87M grant by Flanders Government to further develop its diagnostic biomarker discovery and validation platform
- Can you get to once-a-day? Data-driven strategy rapidly achieves optimal oral drug delivery
- AM-Pharma announces positive results of Phase IIa clinical trial with Alkaline Phosphatase for ulcerative colitis
- Piramed Pharma wins Innovation in Drug Discovery & Development Award at the 2007 UKTI Bioentrepreneurial Company of the Year Awards
- OXFORD GENE TECHNOLOGY LAUNCHES CYTOSURE PRODUCTS FOR THE CYTOGENETICS RESEARCH COMMUNITY
- OXFORD BIOMEDICA SECURES RIGHTS TO ENDOSTATIN AND ANGIOSTATIN GENES FOR CANCER FROM CHILDREN'S HOSPITAL BOSTON
- EMEA approves Kamada’s plans for phase II / III clinical trials of the aerosolized form of AAT for the treatment of Congenital Emphysema
- BioInvent: Directed Issue approved at Extraordinary General Meeting
- OXFORD GENE TECHNOLOGY GRANTS MICROARRAY LICENSE TO APPLIED MICROARRAY INC.
- Santaris Pharma consortium awarded €1.35m by Denmark’s Advanced Technology Foundation for development of the first microRNA medicine
- Malvern shows Zetasizer Nano new chromatography applications at Protein Society Meeting
- Diatos Completes a Series D €9.4 Million Private Financing Round
- amaxa to Co-ordinate Collaboration to Develop High-throughput Devices for Primary Cell Transfection
- OXFORD BIOMEDICA AND SIGMA-ALDRICH ISSUE JOINT LICENCE FOR LENTIVECTOR TECHNOLOGY TO MAJOR BIOTECHNOLOGY COMPANY
- BioPortfolio Biotechnology and Pharmaceutical News April to June 2007
- Syngene Appoints New US Distributors and Sales Manager To Provide Superior Service and Support for US Customers
- ReaX™ Custom Bead Service used for a novel field-based DNA security marking
- Merck Deploys ArisGlobal’s Register™ Globally
- Cellexus Biosystems plc appoints IUL as its exclusive distributor in Austria, Benelux Germany, the Netherlands and Switzerland
- OXFORD GENE TECHNOLOGY GRANTS MICROARRAY LICENSE TO OCEAN RIDGE BIOSCIENCES FOR MICROARRAY SERVICES
- NiKem Research Srl Enters Into Research Service Agreement with InterMune, Inc.
- Genetic Tests for Thrombotic Disease Could Save Lives and Reduce Healthcare Costs
- Celogos Awarded ‘Médaille de la Ville’ for Contribution to Paris Economy
- LifeCycle Pharma to Initiate Phase II Clinical Trial of LCP-Tacro for Organ Transplantation
- LifeCycle Pharma Forms Scientific Advisory Board in Solid Organ Transplantation
- Amsterdam Molecular Therapeutics announces pricing of Initial Public Offering (IPO) on Euronext Amsterdam
- Cellexus Biosystems plc appoints Appropriate Technical Resources Inc. as US Distributor
- BioInvent implements a directed new share issue worth SEK 125 million and summons to an extraordinary shareholders' meeting
- SANTARIS Hanne Damgaard Jensen appointed as SVP Product Development at Santaris Pharma
- Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
- GATC strengthens management team with appointment of Dr Marcus Benz as Chief Operating Officer
- INTEGRAGEN BECOMES FIRST CERTIFIED FRENCH SERVICE PROVIDER FOR ILLUMINA GOLDENGATE AND INFINIUM GENOTYPING
- Pronota strengthens commercial team with appointment of Business Development Directo
- New flu vaccine from PepTcell could provide immunity against all strains of influenza virus
- Agilent Technologies Adds Strength to Its Life Science Business with Acquisition of Stratagene
- TransPharma Medical Receives Second Milestone Payment from Teva Pharmaceutical Industries
- World Leading Cardiologists Join BSP's Scientific Advisory Board
- OXFORD GENE TECHNOLOGY GRANTS MICROARRAY LICENSE TO AUSHON BIOSYSTEMS
- Johnson & Johnson Selects ArisGlobal as its Global Pharmacovigilance and Safety Partner
- IDBS announces the release of E-WorkBook Suite 7.0
- New Feature in 2D Protein Gel Analysis Software Improves Confidence and Productivity in Proteomics Research
- Clinical Data's Cogenics Division Launches Services on Roche 454 GS FLX
- Forbion Announces Successful Exit from Alantos Pharmaceuticals
- Amsterdam Molecular Therapeutics announces launch of Initial Public Offering (IPO) on Euronext Amsterdam
- Faust Pharmaceuticals Present Phase IIa Results for Parkinson's Disease
- Santaris Pharma presents positive clinical data on SPC2996 in Chronic Lymphocytic Leukaemia
- Research centre Jülich and ibidi launch in vivo-like cell cultivation on soft surfaces
- Protagen expands Supervisory Board to support the development and commercialisation of its protein biochips
- Thermo Fisher Scientific Introduces Revolutionary Device for Effective, Long-Lasting Prevention of Waterborne Contamination
- Thrombotargets Corp. and Chemotargets to collaborate on identification of novel hits related with cardiovascular diseases
- Thrombotargets Corp. Announces the Membership of Its New Scientific Advisory Board
- AUSTRIANOVA completes first closing of 35 M EURO Series B financing
- Diatos announces positive Phase I results for DTS-201 Doxorubicin prodrug program
- Cytheris to start two phase I/IIa clinical trials of CYT107, its new recombinant Interleukin-7, in Hepatitis C and oncology
- BPI’s International Impact Honored by PRECARN
- deltaDOT Ltd and Integrated Technologies receive £465k Grant from South East England Development Agency to develop Osprey, a decisive new tool in drug discovery
- AMT Receives Orphan Drug Designation from FDA for AMT 011 for the Treatment of Lipoprotein Lipase Deficiency
- OXFORD BIOMEDICA AND SANOFI-AVENTIS REPORT NEW TROVAX PHASE II TRIAL RESULTS IN RENAL CANCER
- BRANE DISCOVERY ACQUIRES ORL-1 PROGRAM FROM NIKEM RESEARCH
- Isogenica Enters into Research and License Agreement with Wyeth
- Thermo Fisher Scientific Launches New Stackable Shaker
- Cobra awarded DTI Grant to develop Cobra's oral vaccine delivery platform
- AMT Presents Positive Results of Phase I/II Study with Lead Product at Annual Meeting of American Society of Gene Therapy
- LifeCycle Pharma Announces Positive Phase I Clinical Results for its Transplantation Product Candidate, LCP-Tacro
- Free pharmaceutical industry innovation and patent expiration metrics for media outlets
- InferMed appoints new CEO
- Thermo Fisher Scientific Announces New General Purpose Centrifuge System
- Navigate the Fluorescent Minefield with a Free Poster on the "Spectra of Fluorescent Dyes" from Olympus
- Mr. Gilles Brisson to join Cytomics Systems’ Supervisory Board
- BioInvent updates project portfolio
- Pronota strengthens board with appointment of Chairman
- Dr Flemming Ørnskov appointed Chairman of Santaris Pharma Board
- Q Chip launches the ReaXT 'Lab-in-a-Bead' technology - taking the mystery out of PCR
- Arrayjet and BioMicro Systems partner in the USA
- Arrayjet Launches Peerless Benchtop Inkjet Microarray Spotter for R&D Market
- Amsterdam Molecular Therapeutics announces intention to launch an Initial Public Offering (IPO) on Euronext Amsterdam
- Scil Technology GmbH obtained Competent Authority Approval for Phase II Periodontitis Study
- MIP Technologies and Supelco Launch a New Selective SPE Product for Analysis of Tobacco-Specific Nitrosamines
- TTP LABTECH'S MOSQUITO PROVIDES A UNIQUE APPROACH TO HANGING DROP AUTOMATION
- PHASE II RESULTS FOR OXFORD BIOMEDICA'S HI-8 MEL IN MELANOMA TO BE PRESENTED AT AAI MEETING
- Intelligent Design Makes Automated Chemistry Affordable
- Protagen and ZAP partner with Kangdi Antibody Biotech and Bejing Proteome Research Centre to develop antibodies
- Cellexus Biosystems plc launches the CellMaker Lite2TM – the latest generation of its novel disposable bioreactor
- Agilent Technologies’ Mass Spectrometer with HPLC Chip Proves Winning Combo for New Blue Stream Laboratories Facility
- Agilent Technologies Launches New Inductively Coupled Mass Spectrometer Delivering Higher Productivity, More Accurate Results
- Agilent Technologies Receives the 2006 Frost & Sullivan Growth Strategy Leadership Award
- Lectus Therapeutics wins ERBI's Innovation in Drug Discovery and Development Award
- LifeCycle Pharma Receives US Patent for its MeltDose® Technology
- Studies present compelling data on the p16(INK4a) biomarker at the 16th International Congress of Cytology
- New High Resolution Image Analyser - Generates Excellent Results with Qdot Labelled Western Blots
- Nautilus Biotech receives FDA approval for Phase 1 clinical trial in the USA for oral BelerofonR, its long-lasting, Interferon-alpha drug
- Olympus Introduces FV1000 Multi-Laser Combiner System
- New Species Named After Thermo Fisher Scientific: Fissuroderes thermoi
- Targeted Genetics initiates phase I trial for childhood blindness
- Angioblast cleared to trial stem-cell therapy for heart attack patients
- Trexima has demonstrated consistent pain-free results across multiple migraine attacks
- Array BioPharma initiates clinical trials of cancer drug
- Additional indication for Pfizer's Fragmin
- Dr Reddy's: Indian generic Rituxan launch flashes warning to biologics industry
- Magnisense Appoints Business Developer for US Diagnostics Market
- IDBS announces strategic partnership to improve presence and reach of Professional Services in German-speaking regions
- Forbion Capital Partners adds top tier investors to its investor base
- Astech Projects Launch the Astech Automation Challenge
- ILLUMINA INFINIUM BEADCHIPS SELECTED BY GERMANY'S NATIONAL GENOME RESEARCH NETWORK TO SUPPORT ONE OF THE WORLD'S LARGEST GENETIC DISEASE STUDIES TO DATE
- Thrombotargets Corp. and Specs achieve milestone in their Drug Discovery collaboration and announce the beginning of a new Anticoagulant program.
- Thrombotargets inaugurates new facilities at the National Biotechnology Centre (CNB) in Madrid, Spain
- Thrombotargets Corporation relocates to Research Triangle Park in North Carolina
- Thrombotargets Corporation and Instituto Biomar to collaborate on identification and optimization of new drug candidates
- Thrombotargets Corporation Receives Orphan Drug Designation from the U.S. Food and Drug Administration for its Procoagulant Agent, TT-103MH, in the Treatment of Bleeding Episodes in Hemophiliacs
- Midatech Group announces the opening of cGMP standard facility for the production of nanoparticles
- BAC ANNOUNCES COLLABORATION WITH SANOFI PASTEUR FOR VACCINE PURIFICATION
- LifeCycle Pharma signs exclusive license agreement with Sciele Pharma to market a new formulation of fenofibrate in 120mg and 40mg dosage strengths
- GATC Biotech demonstrates new DNA sequencing capability and sequences 9 bacterial genomes in April
- ProtAffin AG secures Series A financing
- Growing medical jobs careersite partners with GeneEd to offer online CME and CE courses
- BioAlliance Pharma presents at BIO 2007
- Amsterdam Molecular Therapeutics BV to present preclinical proof-of-concept data on its gene therapy AMT-020 to treat acute intermittent
- MIP Technologies and Supelco launch a new selective SPE product for the simultaneous extraction of beta agonists and antagonists
- BioAlliance Pharma Announces Consolidated Revenues for Q1 2007
- Nautilus Biotech closes €8.4 million ($11.3 million) investment funding
- Lab21 announces appointment of new Chief Financial Officer
- Biota announces A$16m quarterly royalties from Relenza antiviral
- Protagen launches GMP protein analysis services
- BioAlliance Pharma Announces Participation in Paris SmallCap Event April 26-27
- APPLICATIONS OPEN FOR BURSARIES FOR BSR 2007
- BRANE DISCOVERY LAUNCHED AS SPIN OUT OF R&D PROGRAMMES FROM NIKEM RESEARCH
- Bridgehead International wins The Queen’s Award for Enterprise
- Titian's Mosaic sample management software rapidly becoming industry standard
- The latest in screening data management with ActivityBase XE v7.0
- LANI completes Phase I in Japan and to commence Phase I in UK
- Gene Bridges and BASF sign collaboration agreement
- Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research
- Agilent Technologies First Comprehensive Microarray System for Expression Profiling of Human miRNAs
- Agilent Technologies Announces Belfast Winner of its Largest Ever European Promotional Prize
- New CellReporter live cell based assay system from Genetix
- Thermo Fisher Scientific Introduces Four Advanced Enhancements for its High Content Screening Platform
- CAMBRIDGE ANTIBODY TECHNOLOGY AND PHILOCHEM ANNOUNCE TECHNOLOGY EVALUATION AGREEMENT
- LibraGen Launches its First Family of Active Products Obtained by Enzymatic Transformation of Natural Substances
- BioInvent Interim Report 1 January–31 March 2007
- Hybrigenics' Inecalcitol Shows High Level of Tolerance
- Thermo Fisher Scientific Introduces New -86°C Freezers
- EU Commission issues a major communication on biotechnology - the Biotech industry responds
- Novosom AG acquires exclusive option for CD40-targeted antisense inhibitors from Isis Pharmaceuticals
- TTP LABTECH EXTENDS GLOBAL REACH Success of mosquito® and Acumen® eX3 leads new distribution agreements for Japan, India and Australia New Zealand
- Dymension 2D Gel Analysis Software installed at Specialist University
- Biacore to host DiPIA 2007 conference in Phoenix, Arizona May 6-9, Pointe Hilton Squaw Peak Resort
- More Rapid Than Expected Type 2 Diabetes Incidence Will Drive Diagnostics and Therapeutics Market to $33 Billion by 2016
- Affimed Closes € 25 million (US $ 32 million) Series B financing
- Cytheris Names CFO and CMO as Company Boosts Clinical Development Program in Europe and the US
- BPI Announces First Sales of Next-Generation TISSUEscope ™
- BAC AND GE HEALTHCARE ANNOUNCE FVIII PURIFICATION MEDIA COLLABORATION
- Nautilus Biotech begins Phase I clinical trial in the USA for subcutaneous Belerofon®, its long-lasting, Interferon-alpha drug
- Bt maize crops delivering health, wealth and environmental benefits in Europe
- BioPortfolio Biotechnology and Pharmaceutical News January to March 2007
- CAMBRIDGE ANTIBODY TECHNOLOGY NAMES ITS NEW BUILDING IN HONOUR OF PROFESSOR SIR AARON KLUG
- Roche gains DNA technology in CuraGen unit takeover
- Migraine market: Trexima approval delays benefits generic triptan
- Hollis-Eden requests approval of metabolic drug trial
- Carrington Laboratories to manufacture sublingual vaccines
- Avanir plans restructuring, ends collaborations
- Rise of the superbug set to drive antibacterials growth
- Clinical Data and Roche Sign Co-Marketing Agreement Relating to Cogenics Division Acquisition of 454 GS FLX Sequencing System
- Nitec Pharma AG closes CHF 32 million (approx. US$ 26 million) Series B financing led by NGN Capital
- Cellexus Biosystems appoints Dr Julie Bick as its US-based Chief Scientific Officer
- As Global Fungal Infections Soar, Market for Antifungals Heads for $7 Billion
- Healthy Global Market for Contrasting Agents Growing to $15 Billion by 2010
- $9.8 Billion World Implantable/Injectable Drug Delivery Market Set for Healthy Growth
- OXFORD BIOMEDICA AND SANOFI-AVENTIS ENTER GLOBAL LICENSING AGREEMENT TO DEVELOP AND COMMERCIALISE TROVAX FOR CANCER
- ProFibrix raises up to $ 11 million (€ 8.5 million) Series A financing led by Index Ventures
- HRA Pharma commences UK-based Phase III trial of Ella®, a second-generation emergency contraceptive
- deltaDOT strengthens commercial team with appointment of Vice President, Sales
- Worldwide Lateral Flow Point-of-Care Tests Market to Surpass $2.7 Billion by 2010
- Global Molecular Diagnostics Market...Skyrocketing to $92 Billion by 2016?
- World Vaccine Market Offers Promise of Growth Exceeding $15 Billion in 2012!
- Arrowhead Conferences’ Drug Delivery 2007 to Take Place April 9th-11th 2007 in San Francisco
- Haptogen’s strategy rewarded
- MorphoSys's AbD Serotec Expands Antibody License Agreement with Medical Research Council
- Syrris announce new West Coast office to meet growing customer demand
- Top UK University is First to Install Dyversity 2D Gel Imager
- 9th INTERNATIONAL CONFERENCE ON BIOLOGY AND SYNCHROTRON RADIATION
- SOLVO Biotechnology is introducing the revolutionary BCRP HAM membranes and vesicles!
- Dutch AM-Pharma announces positive results of Phase IIa trial in Acute Renal Failure
- Australian biotech Virax grants French Transgene technology license for immunotherapeutic product
- GSK hay fever drug relieves symptoms
- he FDA has approved Cymbalta to treat generalized anxiety disorder (GAD).
- Abbott cleared to market Crohn's drug in US
- An expert panel has recommended Sanofi-Aventis' avian flu vaccine to the FDA
- Pfizer says HIV drug suppresses virus
- Alzheimer's disease: physicians do not always practice what NICE preaches
- Double-Digit-Growing Cancer Therapeutics Market Could Top $89 Billion by 2011!
- OXFORD BIOMEDICA TO ACQUIRE OXXON THERAPEUTICS
- Deep in vivo Imaging With New Multiphoton Excitation (MPE) Microscope range from Olympus
- Olympus introduces the new 5-megapixel DP25 digital colour camera for microscopes
- Thermo Fisher Scientific Introduces High Precision Bottle-top Dispenser Range.
- Thermo Fisher Scientific Introduces the World's First Electronic Pipette with a Six Language Interface
- Global impact of biotech crops: socio-economic and environmental effects in the first ten years of commercial use
- InforSense® Customer Hub Unveiled to Empower Life Scientists and Informaticians
- Biotechnology industry welcomes calls by EU leaders to act now to deliver sustainable, secure and competitive biofuels
- BioAlliance Pharma Sets Up European Joint Venture with Spepharm to Sell Loramyc(R)
- ACRUX AND ORGANON FURTHER EXPAND THEIR COLLABORATION
- Protagen AG announces the launch of Modiro - The PTM-Explorer
- Cobra joins international consortium to develop oral vaccines
- MedicWave launches Proteinmarker Detection SoftwareTM (PDSTM) 2.0, the state of the art software for proteomic data analysis
- ProNAi and Novosom AG Announce Collaboration to Enable Delivery of DNAi-based Cancer Therapeutics
- Nautilus Biotech and HanAll Pharmaceutical announce license agreement to develop three Nautilus Biotech products in South Korea
- Oxford Gene Technology and Integrated Genomics to Develop a Pichia pastoris Gene Expression Microarray
- LifeCycle Pharma announces approval of its LCP-FenoChol product will not be subject to a so-called 30-month stay under the Hatch-Waxman Act
- OXFORD BIOMEDICA REPORTS AVIAN TRANSGENIC MILESTONE: INTERFERON ALPHA EXPRESSED IN EGGS
- Growing medical jobs careersite partners with GeneEd to offer online CME and CE courses
- Genetix acquisition expands range and scope - Applied Imaging products enhance existing cell biology portfolio
- New 2007 Genetix product guide out now - Cell biology portfolio expands with new applications
- Cytheris Releases Promising Clinical Data on its Interleukin-7 Immune Enhancer at the 2007 CROI Meeting in Los Angeles
- BioAlliance Announces Financial Results For 2006
- Organon and Acrux (ASX:ACR) announce partnership to develop contraceptive sprays
- SYNTAXIN APPOINTS PHILIP BOYD AS CHIEF FINANCIAL OFFICER
- Malvern Instruments secures exclusive distribution rights in the United States, South and Central America for Farfield Scientific analytical instruments
- EU Regulation Urgently Needed! European Patients are Waiting for the Next Generation of Medical Treatments
- Bioindustry welcomes new French legislation covering biosimilar medicines
- EPPOSI calls for greater co-operation between science, industry and regulators
- EU Environment Ministers vote against sound science
- EuropaBio is a founding member of EPAA - A platform for Alternative Approaches to Animal Testing
- Fusion Antibodies signs antibody engineering deal with ARIUS to develop new cancer antibodies
- HRA PHARMA INVEST AN ADDITIONAL EUROS 2.5 M IN CELL THERAPY THROUGH ITS SUBSIDIARY CELOGOS
- Amsterdam Molecular Therapeutics BV receives global rights to develop and commercialize AMT-020 for acute intermittent porphyria
- GSK INITIATES FIRST GLOBAL PHASE III STUDY OF TYKERB® (LAPATINIB) IN HEAD AND NECK CANCER
- Cellexus Biosystems incorporates wholly owned subsidiary in the United States of America
- Nautilus Biotech announces IND filing for Belerofon, its oral, long-lasting, Interferon-alpha drug
- LifeCycle Pharma announces positive data from LCP-AtorFen Phase I clinical program
- Kamada submits clinical program to the EMEA for phases II-III with its leading product
- New ‘chromatography flow-mode’ option transforms Zetasizer Nano into in-line detector for absolute size exclusion chromatography
- Malvern launches SyNIRgi - the sophisticated chemical imaging system for routine use
- Hybrigenics Focuses its Research on Inhibitors of Ubiquitin-Specific Proteases in Cancer
- ALPHA BIOLOGICS SET FOR GROWTH FOLLOWING ACQUISITION OF CTM BIOTECH
- LifeCycle Pharma appoints Senior Vice President of Pharmaceutical Development
- Launch of Biacore X100 brings protein interaction analysis within reach of every life science research lab
- Magnisense and Indicia Announce Joint Testing Platform for Magnetic Marker-Based In Vitro Diagnostics
- Amsterdam Molecular Therapeutics BV enters research collaboration with the University of Barcelona
- STEM CELL SCIENCES AND CELOGOS SIGN A LICENSING DEAL ON AUTOGENOUS MYOBLAST TRANSPLANTATION FOR URINARY INCONTINENCE THERAPY
- BioInvent Financial Statement: 1 January - 31 December 2006
- Cellexus Biosystems recognised by the UK Trade & Investment for its innovative marketing.
- Syngene - New multi-purpose CCD imaging system offers affordable method of analysing all DNA and protein gels
- Nitec Pharma Signs German Marketing Rights for LodotraT to Merck Pharma GmbH
- Unmet Need Drives Innovation in Neurodegenerative Disorder Therapy Market
- The 4th Annual BioFine Europe Convention announces Conference Networking System is now live.
- BioInvent and ThromboGenics Receive Approval to Begin Clinical Trials for Anticoagulant TB-402
- European arable crop profit margins 2006-2007
- EU arable crop margins book 5th edition order form.pdf
- Geneservice acquires the DNA Sequencing facility at Biochemistry Department, University of Oxford
- TTP LabTech: Screening Innovation Drives Big Orders
- Principle biopharmaceutical company introduces ActivityBase XE to improve screening efficiency
- Leading academic center chose IDBS to show ‘best practice’
- ImVisioN Therapeutics strengthens patent position
- BioAlliance Pharma Announces 2006 Consolidated Revenues
- ASTRAZENECA LICENSES REGENERON'S VELOCIMMUNER TECHNOLOGY FOR DISCOVERING HUMAN MONOCLONAL ANTIBODIES
- Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration to Develop Hemophilia Therapies
- Thermo Fisher Scientific Introduces New Platform for Automated Crystallization Plate Production
- Thermo Fisher Scientific Introduces Automated Solution for Assay Ready Cell Culture
- Thermo Fisher Scientific Introduces New Platform for Automated Crystallization Plate Production
- BioAlliance Pharma Raises Free Float to 40 per cent of Capital
- AM-Pharma announces the appointment of Bart Wuurman as CEO
- Thermo Fisher Scientific Introduces New Class II Biological Safety Cabinets
- Cobra Biomanufacturing Plc announces manufacturing agreement with Pharmexa
- Oxford Gene Technology in collaboration with the Wellcome Trust Sanger Institute to develop a microarray to test for genetic defects in unborn children
- Cobra appoints General Manager for Oxford Facility
- Buoyant Order Book Spurs Recruitment Drive at Syrris
- Tailoring the Therapy to the Cancer
- FDA approves Enzon IND for Santaris Pharma's Second New Cancer Drug
- Market for Wireless Technologies in Healthcare Set to Explode
- World Market for Psychotherapeutic Drugs Closes in on $50 Billion in Sales
- Double-Digit Growth Drives Oral Drug Delivery Market to $52 billion by 2010.
- Biomarkers Emerge as High-Growth Worldwide Market for Personalized Medicine
- Double-Digit Growth Expected to Drive World Cell Culture Market to $2.6 Billion
- Blossoming In Vitro Diagnostics Market in India Surpasses $250 Million in 2006
- World Pain Management Drugs and Devices to Top $33 Billion by 2010
- ibidi releases new Chemotaxis Slide
- Scil Technology Completes Patient Enrollment in European Phase II Sinus Lift Study
- OXFORD BIOMEDICA REPORTS AVIAN TRANSGENIC MILESTONE: INTERFERON ALPHA EXPRESSED IN EGGS
- Cellexus Biosystems generates first revenues.
- Dr Walter Wenninger appointed to Santaris Pharma Board
- Nestlé Nutrition enters commercial discussions with Phosphagenics
- OXFORD BIOMEDICA ANNOUNCES PUBLICATION OF AVIAN TRANGENIC RESULTS IN LEADING U.S. SCIENTIFIC JOURNAL
- OXFORD GENE TECHNOLOGY AND AGILENT TECHNOLOGIES ENTER INTO A COLLABORATIVE AGREEMENT
- DanioLabs and Senexis Announce Collaboration on Ageing Related Diseases
- 4- Antibody AG closes CHF 17 Million Series A financing, bringing the total Series A financing to CHF 23 Million ($ 18.5Million)
- BioInvent enters collaboration with Genentech to develop and commercialize BioInvent's proprietary antibody for the treatment of cardiovascular diseases
- Syngene - New GeneTools Software Is World’s First Image Analysis Package to Offer One Step E-Gel 96 Reading
- Ablynx And Boehringer Ingelheim Sign $265 Million Research And Licensing Agreement To Develop New Alzheimer’s Treatments
- Nautilus Biotech launches new website and corporate image
- BioControl Launches International Study of Cardiofit for Heart Failure
- OXFORD GENE TECHNOLOGY GRANTS EXCLUSIVE OPTION TO ITS TRIDEND TECHNOLOGY TO MASSTAG TECHNOLOGIES LTD.
- OXFORD BIOMEDICA'S PHASE III TRIAL OF TROVAX IN RENAL CANCER ADOPTED BY UK CLINICAL TRIAL NETWORK
- Forbion Capital Partners, formerly ABN AMRO Capital Life Sciences, spins out of ABN AMRO Capital and raises a EUR 200 M Life Sciences Fund
- Lectus Therapeutics announces preclinical 'Proof-of-Concept' data
- University of Crete Medical School / novosom AG Receives Funding from Sixth EU Framework Program to develop novel therapy for cancer
- OXFORD GENE TECHNOLOGY AND NIMBLEGEN SYSTEMS, INC. ENTER INTO LICENSING AND SUPPLY AGREEMENTS
- mtm laboratories opens subsidiaries in Italy, France and Spain to support the commercialization of its diagnostic products
- mtm laboratories launches proprietary CINtecR Histology and CINtecR Cytology Kits
- “BioAsia 2007 Thailand” expects to attract over 15,000 visitors worldwide
- OXFORD BIOMEDICA AND SIGMA-ALDRICH ISSUE JOINT LICENCE FOR LENTIVECTOR TECHNOLOGY TO GLAXOSMITHKLINE
- Syrris introduce new reagent injection and product collection modules for AFRICA
- OXFORD BIOMEDICA EXPANDS LICENSING AGREEMENT FOR LENTIVECTOR TECHNOLOGY WITH MAJOR PHARMACEUTICAL COMPANY
- Agilent Technologies’ New Diode-Array and Multiple-Wavelength Detectors Enable Lower Detection Limits
- Agilent Technologies Launches Life Science and Chemical Analysis Centers of Excellence in California, India and Europe
- Agilent Technologies Announces New Technique for Rapid Analysis of Key Breast Milk Component
- BioPortfolio Biotechnology and Pharmaceutical News Archive 2006
- SCIpharm - Exhibitors show support for SCIpharm 200
- Oxford Immunotec announces launch of second generation product based on co-development with Millipore
- Trophos successfully completes phase 1 clinical trials for novel compound to treat neurodegenerative diseases
- Emerging diabetes drugs in early development
- York Pharma: Update on Psoriasis treatment (YP003) ANALYST MEETING TODAY
- Cobra Signs Contract with Replikun Biotech for Novel Gene Therapy Approach
- EUROGENTEST CALLS FOR NEW GENETIC TESTING TECHNOLOGIES
- Sigma Launches Human Plasma Depletion Technology for Proteomics and Human Disease Biomarker Discovery
- STUDY RESULTS DEMONSTRATE ACCURACY OF T-SPOT.TB IN CONTACT TRACING
- CRESSET BIOMOLECULAR DISCOVERY AND BAYER CROPSCIENCE ANNOUNCE A COLLABORATION ON MOLECULAR FIELD TECHNOLOGY
- Phosphagenics initiates animal trials with its anti-cancer compound GTP-0805
- High interest in inhibitors of the novel target sodium-dependent glucose (co-) transporter (SGLT) for therapy of type 2 diabetes
- Apollo Life Sciences Successfully Completes Data Collection for Phase 1b Psoriasis trial
- IMMUNOBIOLOGY LTD (“ImmBio”) ANNOUNCES COMPLETION OF EIGHT MILLION EURO SERIES C FUNDING ROUND
- Sigma-Aldrich Launches SpyLine Poly A+ Capture Kit
- Cobra Biomanufacturing signs agreement with Debiopharm to supply biopharmaceutical protein
- Sigma-Aldrich Expands shRNA Libraries of the RNAi Consortium
- OXFORD BIOMEDICA AND VIRAGEN REPORT AVIAN TRANSGENIC BREAKTHROUGH
- West Pharmaceutical Services' UK Manufacturing Facilities Win Prestigious Safety Award
- ABLYNX ANNOUNCES DEAL WITH NOVARTIS TO DEVELOP THERAPEUTIC NANOBODIES™
- Phosphagenics: successful results from a Phase Ib clinical trial of its transdermal morphine gel
- USDA and DOE to Coordinate Research of Plant and Microbial Genomics: Soybean DNA to be Decoded
- DE NOVO PHARMACEUTICALS ANNOUNCES DRUG DISCOVERY COLLABORATION WITH GENZYME
- Tight race to be the first in a new class of dipeptidyl peptidase IV (DPP-IV) inhibitors for the oral treatment of type 2 diabetes
- Lipoxen plc lists on AIM raising £3.78million
- Novosom announces collaboration with Boehringer Ingelheim
- Peakdale completes peakexplorer GPCR collection for drug discovery
- Minster to collaborate with University of Copenhagen to investigate the potential of tonabersat in the prevention of migrane with aura
- Sigma Introduces New Integrated Lysis and Affinity Purification (iLAP) Columns
- BioInvent Issued US Patent for n-CoDeR Antibody Library
- ABLYNX ANNOUNCES COLLABORATION WITH CENTOCOR RESEARCH AND DEVELOPMENT, INC.
- More farmers worldwide chose biotechnology in 2005 says report
- Living Cells Technologies - LCT raises additional funds from US investors
- Northbank Communications strengthens team with addition of new account manager
- TiGenix closes 16 million Euro Series B financing round and expands shareholder base worldwide
- INTEGRAGEN APPOINTS GERARD VAILLANT AS NON-EXECUTIVE DIRECTOR
- SCYNEXIS Europe is now Selcia following spin off from SCYNEXIS, Inc
- SYMPHOGEN'S SUCCESS IN MANUFACTURING CONSISTENT BATCHES OF POLYCLONAL ANTIBODIES FOR CLINICAL TRIALS ATTRACTS NEW USD 25 MILLION INVESTMENT
- LibraGen signs partnership agreement with Pierre Fabre Medicament R&D
- 9th PHARLEX® pharma license exchange scheduled for May 24-25, 2006, in Sarasota, Florida
- SOLEXA TO PRESENT AT 24th ANNUAL JPMORGAN HEALTHCARE CONFERENCE
- Hybrigenics provides protein interaction screening and analysis tools for Genethon's muscle cell program
- BioPortfolio Biotechnology and Pharmaceutical News January 2006
- BioPortfolio Biotechnology and Pharmaceutical News February 2006
- Living Cell Technologies reports positive meetings with FDA and MedSafe - preparing for cell therapy trials
- BioInvent Financial Statement 1 January - 31 December 2005
- Lectus Therapeutics closes Series A funding round raising £8.2 million
- SIGMA-ALDRICH STRENGTHENS POSITION IN RNAi AND CELL-BASED ASSAYS THROUGH LICENSING AND EQUITY POSITION IN GENOSPECTRA
- Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Sales Growth & Diluted EPS of $.84 in Q4 2005
- Oxford Immunotec launches new website
- Automated Colony Counting of Spiral Plates Improves Patient Care at Major European Teaching Hospital
- New CCD Imager for 2D Protein Gels Is an Accurate, Cost-effective Alternative to Laser Scanners
- NIH TAKES TO ACUMEN EXPLORER TTP LabTech allows NIH to match high content with high throughput
- SOLEXA ANNOUNCES TECHNICAL MILESTONES AT THE AGBT CONFERENCE
- ABLYNX ANNOUNCES RESEARCH COLLABORATION WITH KIRIN BREWERY
- Bio-based economy moves one step closer as Commission publishes new biofuels strategy
- Can therapeutic vaccines fulfill their promise?
- EuropaBio statement on WTO ruling on biotech crops
- MNLpharma announces exclusive licence agreement with Avexa to develop new compounds to treat HIV/AIDS
- Oxford Immunotec's T-SPOT.TB is first test to demonstrate accurate diagnosis of latent TB in HIV patients - Results published in journal AIDS
- Dosing convenience mandates the pipeline of glucagon-like peptide-1 (GLP-1) analogs for type 2 diabetes
- New Technology for Accelerating Development of Vaccines Against H5N1 Flu Enters Pilot Study at ProImmune
- Developing Microarray-based Genetic Tests for Use in NHS Laboratories
- DNAVISION ANNOUNCES DISTRIBUTION AGREEMENT WITH EUROGENTEC FOR PREMATURE MicroRNA QUANTITATION TOOLS
- OXFORD BIOMEDICA ANNOUNCES BOARD APPOINTMENT
- SIGMA-ALDRICH LAUNCHES FIRST LENTIVIRAL shRNA GENE FAMILY SET
- SOLEXA GRANTED EUROPEAN PATENT ON USE OF SINGLE MOLECULES FOR SEQUENCING
- AstraZeneca's Symbicort gives asthma patients the power to get SMART
- COPD: The Silent Killer
- Geneservice Announce the Appointment of Dr Andy Richards as Non-Executive Chairman
- 9th PHARLEX® pharma license exchange partners with the 3rd Annual Florida Tech Transfer Conference
- GemacBio announces the successful conclusion of Phase IIa clinical trials for its new molecule designed to treat multiple sclerosis
- ibidi extends partnership with Applied Biophysics
- BioPortfolio Biotechnology and Pharmaceutical News March 2006
- York Pharma - Announcement date for Interims and update
- York Pharma - Finance Director & other Director Share Purchases
- Blue Membranes approaches US and Japan markets
- InSecta and Moscamed announce strategic marketing partnership for Medfly SIT
- Oxford BioMedica: TroVax clinical trial results to be reported at ASCO meeting
- SOLEXA REPORTS FOURTH QUARTER FINANCIAL RESULTS
- Study results confirm maintained performance of T-SPOT.TB in repeat testing environment
- ProtAffin AG appoint Scientific Advisory Board and Supervisory Board
- PowderMed's Therapeutic DNA Vacc
|
